These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7731707)

  • 1. Proto-oncogenic properties of the DP family of proteins.
    Jooss K; Lam EW; Bybee A; Girling R; Müller R; La Thangue NB
    Oncogene; 1995 Apr; 10(8):1529-36. PubMed ID: 7731707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
    Ormondroyd E; de la Luna S; La Thangue NB
    Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S; Allen KE; Mason SL; La Thangue NB
    EMBO J; 1999 Jan; 18(1):212-28. PubMed ID: 9878064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B; Farmer AA; Lee WH
    Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new component of the transcription factor DRTF1/E2F.
    Girling R; Partridge JF; Bandara LR; Burden N; Totty NF; Hsuan JJ; La Thangue NB
    Nature; 1993 Mar; 362(6415):83-7. PubMed ID: 8446173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
    Pasteau S; Loiseau L; Arnaud L; Trembleau A; Brun G
    Oncogene; 1995 Oct; 11(8):1475-86. PubMed ID: 7478572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
    Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
    Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control by E2F.
    Adams PD; Kaelin WG
    Semin Cancer Biol; 1995 Apr; 6(2):99-108. PubMed ID: 7647312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional characterisation of E2F-5, a new member of the E2F family.
    Buck V; Allen KE; Sørensen T; Bybee A; Hijmans EM; Voorhoeve PM; Bernards R; La Thangue NB
    Oncogene; 1995 Jul; 11(1):31-8. PubMed ID: 7542760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Xenopus laevis DP proteins.
    Girling R; Bandara LR; Ormondroyd E; Lam EW; Kotecha S; Mohun T; La Thangue NB
    Mol Biol Cell; 1994 Oct; 5(10):1081-92. PubMed ID: 7865876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous E2F expression is growth inhibitory before, during, and after cellular transformation.
    Lee TA; Farnham PJ
    Oncogene; 2000 Apr; 19(18):2257-68. PubMed ID: 10822376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.